• OPEN AN ACCOUNT
Indian Indices
Nifty
25,044.35 72.45
(0.29%)
Sensex
82,587.89 532.78
( 0.65%)
Bank Nifty
56,461.90 402.55
( 0.72%)
Nifty IT
38,417.95 3.85
( 0.01%)
Global Indices
Nasdaq
43,117.37 514.58
(1.21%)
Dow Jones
6,114.62 68.45
(1.13%)
Hang Seng
38,777.68 423.59
(1.10%)
Nikkei 225
8,758.99 0.95
(0.01%)
Forex
USD-INR
86.62 0.13
(0.15%)
EUR-INR
99.78 0.17
(0.17%)
GBP-INR
116.55 0.28
(0.24%)
JPY-INR
0.59 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524636
INE102E01018
-6.931875
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
450.2
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

KCD Industries India Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday 14Th February 2025
Feb 14,2025
Dear Sir/Madam This is to notify the exchange that the Board of Directors of the Company at their meeting held today i.e. Friday 14th February 2025 at the Registered Office of the Company considered and approved Un-audited Standalone & Consolidated Financial Results for quarter and nine months ended as on 31st December 2024; Further a copy of the said financial results along with the Limited Review Report issued by the Statutory Auditors thereon is enclosed herewith. The meeting of the Board of Directors commenced at 3.10 P.M. and concluded at 3.40 P.M.